EIF FUND
July 1st, 2002
BY KEITH NUTHALLTHE EUROPEAN Investment Fund has agreed to invest Euro 25 million in "Merlin Biosciences III," a pan-European scheme investing on infant companies that develop human healthcare products or allied technologies. Merlin Biosciences III will exclusively focus on biosciences, with particular attention to post-genomics, cell therapy, computational approaches to biosciences, bionics, nano-technology and system biology. It will work across the EU, and although it will invest principally in Britain, Germany, France and Scandinavian countries, it will also ...
Full access to this article can be arranged with permission from the client that first ordered it. Please contact us to request access. Entries are uploaded to our archive at least one year after being published by a client – free access is restricted to International News Services journalists for background research only. The article date indicates when copy was filed to a client, not when posted to this archive. Upon client requests, International News Services will remove such articles from the archive or not upload them in the first place. They are included to demonstrate the breadth of topics undertaken by the agency and also to help promote clients’ coverage.